| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005930 | axoneme | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 12 |
| GO:0005929 | cilium | 4 | 10 |
| GO:0042995 | cell projection | 2 | 10 |
| GO:0043226 | organelle | 2 | 10 |
| GO:0043227 | membrane-bounded organelle | 3 | 10 |
| GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
Related structures:
AlphaFold database: Q4QHK2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.361 |
| DEG_APCC_DBOX_1 | 53 | 61 | PF00400 | 0.340 |
| DOC_CDC14_PxL_1 | 144 | 152 | PF14671 | 0.329 |
| DOC_CYCLIN_RxL_1 | 148 | 156 | PF00134 | 0.405 |
| DOC_MAPK_gen_1 | 100 | 109 | PF00069 | 0.361 |
| DOC_MAPK_gen_1 | 189 | 197 | PF00069 | 0.454 |
| DOC_MAPK_MEF2A_6 | 191 | 199 | PF00069 | 0.466 |
| DOC_PP2B_LxvP_1 | 145 | 148 | PF13499 | 0.285 |
| DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.473 |
| LIG_14-3-3_CanoR_1 | 106 | 110 | PF00244 | 0.351 |
| LIG_14-3-3_CanoR_1 | 151 | 156 | PF00244 | 0.405 |
| LIG_14-3-3_CanoR_1 | 74 | 81 | PF00244 | 0.448 |
| LIG_Actin_WH2_2 | 77 | 94 | PF00022 | 0.426 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.643 |
| LIG_BRCT_BRCA1_1 | 37 | 41 | PF00533 | 0.458 |
| LIG_CSL_BTD_1 | 115 | 118 | PF09270 | 0.405 |
| LIG_FHA_2 | 160 | 166 | PF00498 | 0.557 |
| LIG_LIR_Gen_1 | 198 | 203 | PF02991 | 0.428 |
| LIG_LIR_Gen_1 | 207 | 214 | PF02991 | 0.433 |
| LIG_LIR_Gen_1 | 87 | 94 | PF02991 | 0.334 |
| LIG_LIR_Nem_3 | 115 | 119 | PF02991 | 0.390 |
| LIG_LIR_Nem_3 | 173 | 177 | PF02991 | 0.426 |
| LIG_LIR_Nem_3 | 190 | 196 | PF02991 | 0.490 |
| LIG_LIR_Nem_3 | 198 | 202 | PF02991 | 0.366 |
| LIG_LIR_Nem_3 | 207 | 213 | PF02991 | 0.252 |
| LIG_LIR_Nem_3 | 87 | 91 | PF02991 | 0.321 |
| LIG_MAD2 | 151 | 159 | PF02301 | 0.384 |
| LIG_PCNA_yPIPBox_3 | 103 | 117 | PF02747 | 0.414 |
| LIG_Pex14_2 | 37 | 41 | PF04695 | 0.458 |
| LIG_PTB_Apo_2 | 155 | 162 | PF02174 | 0.405 |
| LIG_PTB_Phospho_1 | 155 | 161 | PF10480 | 0.384 |
| LIG_SH2_CRK | 88 | 92 | PF00017 | 0.337 |
| LIG_SH2_NCK_1 | 43 | 47 | PF00017 | 0.339 |
| LIG_SH2_PTP2 | 174 | 177 | PF00017 | 0.552 |
| LIG_SH2_SRC | 174 | 177 | PF00017 | 0.633 |
| LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.657 |
| LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.561 |
| LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.439 |
| LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.422 |
| LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.345 |
| LIG_SUMO_SIM_anti_2 | 55 | 61 | PF11976 | 0.358 |
| LIG_SUMO_SIM_par_1 | 151 | 156 | PF11976 | 0.304 |
| LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.304 |
| LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.618 |
| LIG_WRC_WIRS_1 | 196 | 201 | PF05994 | 0.417 |
| MOD_CDK_SPK_2 | 69 | 74 | PF00069 | 0.473 |
| MOD_CK1_1 | 87 | 93 | PF00069 | 0.485 |
| MOD_CK1_1 | 96 | 102 | PF00069 | 0.357 |
| MOD_CK2_1 | 10 | 16 | PF00069 | 0.527 |
| MOD_CK2_1 | 159 | 165 | PF00069 | 0.546 |
| MOD_CK2_1 | 222 | 228 | PF00069 | 0.515 |
| MOD_CK2_1 | 99 | 105 | PF00069 | 0.368 |
| MOD_GlcNHglycan | 182 | 186 | PF01048 | 0.571 |
| MOD_GSK3_1 | 177 | 184 | PF00069 | 0.546 |
| MOD_GSK3_1 | 31 | 38 | PF00069 | 0.370 |
| MOD_GSK3_1 | 69 | 76 | PF00069 | 0.463 |
| MOD_GSK3_1 | 90 | 97 | PF00069 | 0.468 |
| MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.466 |
| MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.390 |
| MOD_NEK2_1 | 3 | 8 | PF00069 | 0.687 |
| MOD_NEK2_1 | 35 | 40 | PF00069 | 0.371 |
| MOD_NEK2_1 | 84 | 89 | PF00069 | 0.319 |
| MOD_NEK2_2 | 31 | 36 | PF00069 | 0.482 |
| MOD_PKA_2 | 73 | 79 | PF00069 | 0.452 |
| MOD_PKA_2 | 99 | 105 | PF00069 | 0.391 |
| MOD_PKB_1 | 149 | 157 | PF00069 | 0.384 |
| MOD_Plk_1 | 84 | 90 | PF00069 | 0.409 |
| MOD_Plk_1 | 94 | 100 | PF00069 | 0.353 |
| MOD_Plk_4 | 10 | 16 | PF00069 | 0.678 |
| MOD_Plk_4 | 112 | 118 | PF00069 | 0.384 |
| MOD_Plk_4 | 170 | 176 | PF00069 | 0.552 |
| MOD_Plk_4 | 198 | 204 | PF00069 | 0.519 |
| MOD_Plk_4 | 31 | 37 | PF00069 | 0.399 |
| MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.467 |
| TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.429 |
| TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.438 |
| TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.345 |
| TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.309 |
| TRG_ER_diArg_1 | 148 | 151 | PF00400 | 0.384 |
| TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.484 |
| TRG_ER_diArg_1 | 223 | 226 | PF00400 | 0.534 |
| TRG_NES_CRM1_1 | 123 | 133 | PF08389 | 0.279 |
| TRG_Pf-PMV_PEXEL_1 | 125 | 129 | PF00026 | 0.269 |
| TRG_Pf-PMV_PEXEL_1 | 151 | 156 | PF00026 | 0.405 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7B1 | Leptomonas seymouri | 61% | 100% |
| A0A0S4J897 | Bodo saltans | 46% | 83% |
| A0A1X0NQ44 | Trypanosomatidae | 54% | 100% |
| A0A3S7WQZ4 | Leishmania donovani | 94% | 100% |
| A0A422NRS7 | Trypanosoma rangeli | 54% | 100% |
| A4H5Z9 | Leishmania braziliensis | 81% | 100% |
| A4HUC5 | Leishmania infantum | 95% | 100% |
| C9ZVG5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
| E9AN24 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
| Q5FVI3 | Rattus norvegicus | 28% | 100% |
| Q8N456 | Homo sapiens | 27% | 91% |
| Q8N9N7 | Homo sapiens | 28% | 100% |
| Q9D1G5 | Mus musculus | 28% | 100% |
| V5BIH6 | Trypanosoma cruzi | 53% | 100% |